AC-262536
AC-262 is a drug developed by Acadia Pharmaceuticals that acts as a selective androgen receptor modulator (SARM). Chemically, it exhibits endo-exo isomerism, with the endo form being the biologically active form.
It acts as a partial agonist of the androgen receptor with a binding affinity (Ki) of 5 nM. In addition, it shows no significant affinity for other receptors studied.
In animal studies, AC-262536 has shown a maximum anabolic effect that is approximately 66% of the anabolic potency of testosterone, and only approximately 27% of the androgenic potency of testosterone.
DISCLAIMER
This material is sold for laboratory research use only. Terms and conditions of sale apply. Not for human consumption, medical, veterinary or household use. Please familiarize yourself with our DISCLAIMER before ordering.
Data sheet
AC-262536 – oplossing, 300mg (10mg/mL)
|
Application |
SARM, AR partial agonist |
|
CAS |
870888-46-3 |
|
Molar massa |
278.348 g/mol |
|
Chemical formula |
C 18 H 18 N 2 O |
|
IUPAC name |
4-(3-hydroxy-8-azabicyclo[3.2.1]octaan-8-yl)naphthalene-1-carbonitri |
|
Synonyms |
AC-262.536, AC-262536, CHEMBL468938, SCHEMBL4879629 |
|
Bulletin |
Store at room temperature, tightly closed, away from heat, light and moisture. |
|
Solubility |
|
|
Organoleptic profile |
|
|
Physical form |
Powder |
|
Specification |
≥99% |
|
Conditions |
This material is sold for laboratory research use only. Terms and conditions of sale apply. Not for human consumption, medical, veterinary or household use. Please familiarize yourself with our DISCLAIMER before ordering. |
Choose options
